CBA
OCUL icon

Coastal Bridge Advisors’s Ocular Therapeutix OCUL Stock Holding History

Coastal Bridge Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,900
Closed -$57.5K – 182
2023
Q4 		$57.5K Buy
+12,900
New +$38.1K 0.01% 167
2023
Q3 		– Sell
-10,900
Closed -$56.2K – 178
2023
Q2 		$56.2K Buy
+10,900
New +$64.8K 0.01% 161
2022
Q1 		– Sell
-21,800
Closed -$152K – 199
2021
Q4 		$152K Buy
+21,800
New +$169K 0.03% 190

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Coastal Bridge Advisors's OCUL Position: Q1 2024 in Review

Coastal Bridge Advisors sold out of Ocular Therapeutix (OCUL) in Q1 2024, closing a stake of 12,900 shares — an estimated $57.5K sold.

Coastal Bridge Advisors first reported a position in OCUL in Q4 2021 and held it in 3 quarters. The position peaked at $152K in Q4 2021. 148 funds tracked by Wall St. Rank hold OCUL as of Q1 2024.

  • Coastal Bridge Advisors reported no remaining Ocular Therapeutix position as of Q1 2024 after selling out during the quarter.
  • Coastal Bridge Advisors sold 12,900 Ocular Therapeutix shares in Q1 2024, an estimated $57.5K.
  • Coastal Bridge Advisors first reported a position in Ocular Therapeutix in Q4 2021 and held it in 3 quarters.
  • Coastal Bridge Advisors's Ocular Therapeutix position peaked at $152K in Q4 2021.
  • 148 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2024.

Based on Coastal Bridge Advisors's 13F filing for Q1 2024, filed 15 May 2024.